Swan Capital’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.1K Buy
110
+10
+10% +$2.65K 0.02% 87
2026
Q1
$11K Hold
100
﹤0.01% 193
2025
Q4
$16.6K Sell
100
-19
-16% -$3.18K 0.01% 140
2025
Q3
$23.3K Buy
119
+11
+10% +$1.81K 0.01% 112
2025
Q2
$9.77K Buy
+108
New +$8.53K ﹤0.01% 166

Other funds holding ALAB

Swan Capital's ALAB Position: Q2 2026 in Review

Swan Capital increased its Astera Labs (ALAB) stake by 10% in Q2 2026, buying an estimated $2.65K and bringing the position to 110 shares worth $53.1K. The position accounts for 0.02% of the portfolio, ranked #87.

Swan Capital first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Swan Capital held 110 shares of Astera Labs worth $53.1K as of Q2 2026.
  • Swan Capital bought 10 Astera Labs shares in Q2 2026, an estimated $2.65K.
  • Astera Labs made up 0.02% of Swan Capital's portfolio in Q2 2026, its #87 holding.
  • Swan Capital first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.